Evedientes, Jun Mae .
HRN: 23-53-45 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/19/2024
MUPIROCIN 2%, 15G (TUBE)
03/19/2024
03/21/2024
TOPICAL
As Needed
BID
Possible IV Site Infection
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes